Illinois Pharmacy CE Requirement 30-Hour Package
This 30 hour package is perfect for Illinois Pharmacists looking to fulfill all of their IL CE requirements.
Included Courses
Courses included in this package. Click on a course to learn more.
- Addiction Medicine Part 2: Alcohol 2Course Release Date: 10/21/22
Alcohol use disorder is a serious national health problem in the United States. It is estimated that more than 14 million American adults had an alcohol use disorder in 2019, as well as 414,000 adolescents aged 12 to 17. There is a clear need for improvement in the treatment of alcohol use disorder; this course serves to review the recognition, diagnosis, and treatment of alcohol use disorder and alcohol withdrawal.
- Educating Patients: Creating Teaching Moments in Practice 4Course release date: 12/21/2022
About the Course
Effective education is essential to help patients and family gain knowledge. All healthcare professionals (HCPs) can identify teaching opportunities to assess and provide effective education. The purpose of this course is to provide HCPs with current evidence-based information to help them learn and apply skills and practice for effective patient and family teaching in a variety of settings. - Evidence-Based Implicit Bias Implications for Physicians and Healthcare Professionals 1Course release date: 12/23/2021
About the Course:
The purpose of this course is to provide a historical context of race and racism and its relationship to the development of racial implicit bias. The development of implicit bias will be discussed along with research demonstrating the impact of implicit bias on the clinical encounter. Recommendations for mitigating implicit bias are offered. - Heart Failure: Evidence Review and Management 2Release Date: 8/10/2022
About the Course
Heart failure is a complex clinical syndrome associated with increasing morbidity, mortality, and economic burden. Despite evidence supporting guideline-directed therapy and management for reduction of morbidity and mortality, these medications are still underprescribed. According to the CHAMP-HF registry, among eligible patients, only 22% were prescribed essential heart failure medications per guideline recommendations ((Greene et al., 2018). Healthcare providers have an essential role in improving outcomes with heart failure by bridging the gap between guideline-directed recommendations and actual clinical practice. The learning outcomes of this activity will help clinicians understand this healthcare gap by reviewing the current evidence-based pharmacotherapy recommendations for HF treatment through analyzing clinical trials and guidelines.
- Management Of Drug Challenges: Generic vs Branded Drugs, 2nd Edition 1Course release date: 10/31/2022
About the Course
Written program is designed to help healthcare professionals best understand the generic drug environment, recognize when substitution is warranted, and work with their patients to fully understand and appreciate the process.
- Monitoring Techniques for Optimal Diabetes Management and Control 2Course release date: 10/12/2022
About this Course
The purpose of this course is to assist in the successful management of diabetes, including blood glucose monitoring (BGM) and the ability of persons with diabetes to monitor the effectiveness of their diabetes treatment plan to understand better the interrelationships of food, activity, and medication-taking. In addition, BGM data can alert the person to hypoglycemia and hyperglycemia, inspiring lifestyle modifications that may help people with diabetes achieve their A1C goals. Diabetes technology has resulted in many improvements in blood glucose meters. Continuing advances in BGM have led to the development of continuous glucose monitoring (CGM) systems that enable people with diabetes to optimize glycemic stability and improve the quality of their lives. This course reviews the features and functionality of BGM with glucometers and CGMs in line with the 2022 American Diabetes Association (ADA) evidence-based guidelines integrated into clinical practice.
- Pharmacological Management: Type 2 Diabetes in Children, 2nd Edition 3
Course release date: 1/26/2023
About the Course
This course will outline the risk factors, pathophysiology, and diagnostic criteria of type 2 diabetes. Goals of management, treatment options, and psychosocial barriers will also be addressed to guide successful multidisciplinary care of these patients. - Prescribing Controlled Substances Safely: A DEA Requirement 8
Course release date: 5/1/2023
About the Course
Nurse Practitioners (NPs), Physician Assistants (PAs), Pharmacists, and Dentists care for patients with disorders in many healthcare settings. Individuals may seek care for an acute illness or worsening of a chronic condition. Often, pain is the leading reason for seeking medical care. Appropriate prescribing practices are critical for all medications, but controlled substances require special attention. The Drug Enforcement Agency (DEA), the Food and Drug Administration (FDA), and the U.S. Department of Health and Human Services (HHS) all have a role in controlled medication schedules. Prescribers must understand federal and state requirements for all controlled substances. This course will provide a general review of federal and state-controlled substance regulations and the prescribing practices for controlled substances. Additionally, substance use disorders are complex phenomena affecting many lives. This course also reviews common substance use disorders, including alcohol, anxiolytics, stimulants, hallucinogens, and tobacco/vaping. However, the focus is on clinical safety considerations when prescribing non-cancer-related opioid medications for acute/chronic pain in adults.
- Preventing Sexual Harassment in the Workplace for Illinois Professionals, 2nd edition 1
Release Date: 7/10/2023
About the courseThis basic-level course will help Illinois Healthcare professionals identify sexual harassment in the workplace, prevent it, and take appropriate action if it occurs.
- Rhinitis: Treatment Strategies for Healthcare Providers 1Course Release date: 12/26/2022
The purpose of this course is to explain the epidemiology of rhinitis, discuss the pathophysiology of allergic and nonallergic rhinitis, review assessment and diagnostic testing for rhinitis, and describe the pharmacological and nonpharmacological treatment strategies of allergic and nonallergic rhinitis. - Shingles Disease Process and Vaccination for Pharmacists 1Release Date: 01/17/2022
About the Course:
Shingles causes a characteristic rash typically localized in one area of the body. Serious complications, which often depend on the rash location, can arise, such as pain that persists after the rash has cleared and even vision or hearing loss. Treatment typically focuses on antiviral therapy and symptom control. Shingles can be prevented through vaccination, which is recommended for adults over 50 since the immune system weakens with age. This course serves to review the disease process of shingles and the use of vaccinations to prevent shingles. - The Complications of Chronic Kidney Disease, Second Edition 2
Release Date: 7/10/2023
About the Course:
This course serves as a review of chronic kidney disease (CKD) and the medications used to prevent adverse effects of CKD and slow disease progression. - The Pharmacologic Management of Anxiety in Adults 2Release Date: 7/10/2023About the CourseAnxiety disorders are the most commonly diagnosed psychiatric disorders, with an estimated 264 million persons globally suffering from an anxiety disorder. It’s estimated that 19.1% of adults in the United States (U.S.) are affected by at least one anxiety disorder; this number increases to 31.9% in U.S. adolescents. Common anxiety disorders include generalized anxiety disorder (GAD), panic disorder (PD), specific phobias, agoraphobia, social anxiety disorder (SAD), and separation anxiety disorder. This course reviews the diagnosis and pharmacological management of anxiety disorders, as well as medications which can cause or exacerbate anxiety symptoms.